Topics (PIVAC):
- Immunotherapeutic targets for the treatment of adult B-cell acute lymphocytic leukaemia
- Ageing and the human immune system in the era of cancer immunotherapy
- Epitope Spreading to Enhance the Effectiveness of TCR Transduced T Cells
- The gap between the epitopes predicted, and those actually recognized by CD8 T cells
- The exercise of TAMing the immune system
- T cell suppression by cancer cells
- The amino acid transporter xCT in breast cancer (stem) cells
- T-cell monitoring for clinical studies: main techniques, pitfalls, and quality assurance
- New generation of personalized cancer vaccines
- The cross-talk between cancer and myeloid cells promotes tumor development by immune dependent and independent mechanisms
- New strategies to reprogram dysfunctional tumor-infiltrating T cells in paediatric high-risk neuroblastoma
- Assessment of Antibody Affinity Using ELISPOT/Fluorospot
- Cancer Immune Escape: MHC expression in primary tumors “versus” metastatic lesions
- NK cell immunosenescence and NK cell-based immunotherapy in AML patients
- Ιn situ cancer vaccines: Tumor ablation and immune stimulation
- Targeting aGARP on human Tregs: a novel approach for the immunotherapy of cancer?
- Role of miRNAs and RNA-binding proteins for the immune escape of tumors
- Adoptive T-cell therapy in academia – Oslo experiences
- Survival of the fittest: How do myeloid-derived suppressor cells (MDSC) survive in the inhospitable tumor microenvironment?